Sweden
# |
Name |
EBIT |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 401.22 M
|
Dec. 31, 2023 | USD 29.22 | -3.00% |
|
Sweden |
|
2 |
USD 120.91 M
|
Dec. 31, 2023 | USD 4.60 | 0.04% |
|
Sweden |
|
3 |
USD 97.12 M
|
Dec. 31, 2023 | USD 8.44 | 1.06% |
|
Sweden |
|
4 |
USD 92.43 M
|
Dec. 31, 2024 | USD 3.53 | -1.01% |
|
Sweden |
|
5 |
USD 82.78 M
|
Dec. 31, 2023 | USD 18.49 | 0.08% |
|
Sweden |
|
6 |
USD 61.88 M
|
Dec. 31, 2023 | USD 13.28 | -2.29% |
|
Sweden |
|
7 |
USD 54.35 M
|
Dec. 31, 2023 | USD 52.33 | -2.11% |
|
Sweden |
|
8 |
USD 47.80 M
|
Dec. 31, 2023 | USD 3.55 | -2.70% |
|
Sweden |
|
9 |
USD 37.31 M
|
Dec. 31, 2023 | USD 3.19 | -1.80% |
|
Sweden |
|
10 |
USD 31.39 M
|
Dec. 31, 2023 | USD 0.21 | -4.72% |
|
Sweden |
|
11 |
USD 27.33 M
|
Dec. 31, 2023 | USD 18.98 | -4.07% |
|
Sweden |
|
12 |
USD 16.53 M
|
Dec. 31, 2023 | USD 19.20 | -5.48% |
|
Sweden |
|
13 |
USD 7.95 M
|
Dec. 31, 2024 | USD 41.47 | -0.80% |
|
Sweden |
|
14 |
USD 6.86 M
|
Dec. 31, 2023 | USD 2.53 | -0.42% |
|
Sweden |
|
15 |
USD 5.41 M
|
Dec. 31, 2023 | USD 2.25 | -17.68% |
|
Sweden |
|
16 |
USD 4.86 M
|
Dec. 31, 2023 | USD 3.64 | -2.31% |
|
Sweden |
|
17 |
USD 4.11 M
|
Dec. 31, 2023 | USD 20.58 | -5.59% |
|
Sweden |
|
18 |
USD 4.08 M
|
Dec. 31, 2023 | USD 0.79 | -7.19% |
|
Sweden |
|
19 |
USD 1.81 M
|
Dec. 31, 2023 | USD 2.77 | -4.78% |
|
Sweden |
|
20 |
USD 61.19 K
|
Dec. 31, 2023 | USD 0.22 | -4.95% |
|
Sweden |
|
21 |
USD -175.98 K
|
Dec. 31, 2023 | USD 0.81 | -4.47% |
|
Sweden |
|
22 |
USD -249.41 K
|
Dec. 31, 2023 | USD 0.14 | 2.05% |
|
Sweden |
|
23 |
USD -976.14 K
|
Dec. 31, 2023 | USD 0.38 | -3.14% |
|
Sweden |
|
24 |
USD -1.21 M
|
April 30, 2024 | USD 0.13 | -1.11% |
|
Sweden |
|
25 |
USD -1.52 M
|
Dec. 31, 2023 | USD 0.27 | -2.38% |
|
Sweden |
|
26 |
USD -1.57 M
|
Dec. 31, 2023 | USD 0.47 | -2.96% |
|
Sweden |
|
27 |
USD -1.62 M
|
Dec. 31, 2023 | USD 0.12 | -1.48% |
|
Sweden |
|
28 |
USD -1.63 M
|
Dec. 31, 2023 | USD 0.25 | -3.82% |
|
Sweden |
|
29 |
USD -1.69 M
|
Dec. 31, 2023 | USD 0.31 | 1.24% |
|
Sweden |
|
30 |
USD -1.73 M
|
Dec. 31, 2023 | USD 0.84 | -2.95% |
|
Sweden |
|
31 |
USD -1.74 M
|
Dec. 31, 2023 | USD 0.16 | -2.74% |
|
Sweden |
|
32 |
USD -1.94 M
|
Dec. 31, 2023 | USD 0.09 | -2.04% |
|
Sweden |
|
33 |
USD -2.12 M
|
Dec. 31, 2023 | USD 0.18 | -3.03% |
|
Sweden |
|
34 |
USD -2.75 M
|
Dec. 31, 2023 | USD 0.85 | -1.32% |
|
Sweden |
|
35 |
USD -3.52 M
|
Dec. 31, 2023 | USD 0.21 | 1.47% |
|
Sweden |
|
36 |
USD -3.67 M
|
Dec. 31, 2023 | USD 1.25 | -0.41% |
|
Sweden |
|
37 |
USD -3.78 M
|
Dec. 31, 2023 | USD 0.12 | -10.10% |
|
Sweden |
|
38 |
USD -4.07 M
|
Aug. 31, 2024 | USD 0.26 | 0.92% |
|
Sweden |
|
39 |
USD -4.48 M
|
Dec. 31, 2023 | USD 0.39 | -4.99% |
|
Sweden |
|
40 |
USD -4.70 M
|
Dec. 31, 2023 | USD 0.13 | 0.88% |
|
Sweden |
|
41 |
USD -5.80 M
|
Dec. 31, 2023 | USD 1.59 | -2.74% |
|
Sweden |
|
42 |
USD -6.40 M
|
Dec. 31, 2023 | USD 0.09 | -2.98% |
|
Sweden |
|
43 |
USD -6.85 M
|
Dec. 31, 2023 | USD 0.19 | -8.49% |
|
Sweden |
|
44 |
USD -9.24 M
|
Dec. 31, 2023 | USD 0.09 | 11.18% |
|
Sweden |
|
45 |
USD -9.78 M
|
Dec. 31, 2023 | USD 1.64 | -3.31% |
|
Sweden |
|
46 |
USD -9.99 M
|
Dec. 31, 2023 | USD 0.71 | 8.98% |
|
Sweden |
|
47 |
USD -10.82 M
|
Dec. 31, 2023 | USD 0.26 | -2.13% |
|
Sweden |
|
48 |
USD -11.34 M
|
Dec. 31, 2023 | USD 2.47 | -3.20% |
|
Sweden |
|
49 |
USD -11.67 M
|
April 30, 2024 | USD 0.18 | -8.41% |
|
Sweden |
|
50 |
USD -13.46 M
|
Dec. 31, 2023 | USD 0.50 | -2.16% |
|
Sweden |
The Healthcare company in Sweden with the highest EBIT is Swedish Orphan Biovitrum AB (publ) (Stockholm Stock Exchange: SOBI.ST) at USD 401.22 M.
The Healthcare company in Sweden with the lowest EBIT is Vitrolife AB (publ) (Stockholm Stock Exchange: VITR.ST) at USD -356.31 M.
The top 10 Healthcare companies in Sweden by EBIT are Swedish Orphan Biovitrum AB (publ), Attendo AB (publ), Ambea AB (publ), Arjo AB (publ), Medicover AB (publ), AddLife AB (publ), Camurus AB (publ), Vimian Group AB (publ), Humana AB (publ) and ADDvise Group AB (publ).
The bottom 10 Healthcare companies in Sweden by EBIT are Vitrolife AB (publ), Hansa Biopharma AB (publ), BioInvent International AB (publ), Egetis Therapeutics AB (publ), Vicore Pharma Holding AB (publ), Cantargia AB (publ), Oncopeptides AB (publ), SynAct Pharma AB, Xspray Pharma AB (publ) and IRLAB Therapeutics AB (publ).